| 000 | 00986 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515011607.0 | ||
| 264 | 0 | _c20060628 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1517/14656566.7.1.25 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeLoughery, Thomas G | |
| 245 | 0 | 0 |
_aManagement of bleeding emergencies: when to use recombinant activated factor VII. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cJan 2006 |
||
| 300 |
_a25-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 |
_aEmergencies _xepidemiology |
| 650 | 0 | 4 |
_aFactor VIIa _xtherapeutic use |
| 650 | 0 | 4 |
_aHemorrhage _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 7 _gno. 1 _gp. 25-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.7.1.25 _zAvailable from publisher's website |
| 999 |
_c15989845 _d15989845 |
||